CARY, NC--(Marketwire - Nov 7, 2012) - Cornerstone Therapeutics Inc. (
Mr. McEwan is a pharmaceutical industry executive with more than 30 years experience. He has been instrumental in numerous strategic initiatives, notably in the healthcare sector, including public and private mergers and acquisitions, divestments and capital restructuring, and organizational restructuring and combinations. He has served in many senior management positions and on executive boards and Boards of Directors including those of Averion International and Inveresk Research. He is a previous chairman of the Cornerstone Board of Directors.
"We are delighted to have Alastair join our executive management team as CFO," said Craig A. Collard, Cornerstone's Chief Executive Officer. "This is an exciting time at Cornerstone as we continue to grow through the acquisition of companies and products that fit within our core focus areas in the hospital market. Alastair shares our strategic vision for the Company and will play a critical role as we work to further establish our presence and reputation as a leader in the hospital and related specialty markets."
Mr. McEwan earned his Bachelor of Commerce degree from the University of Edinburgh, and is a chartered accountant under the Institute of Chartered Accountants of Scotland.
About Cornerstone Therapeutics
Cornerstone Therapeutics Inc. (
- Board & Management Changes
- Investment & Company Information
- pharmaceutical company